Canada markets closed

H-CYTE, Inc. (HCYT)

Other OTC - Other OTC Delayed Price. Currency in USD
Add to watchlist
6.000.00 (0.00%)
At close: 10:12AM EDT
Show:
Balance Sheet
Cash Flow
Annual

Income Statement

All numbers in thousands
Breakdown
ttm
2021-12-31
2020-12-31
2019-12-31
2018-12-31
Total Revenue
1,238
1,612
2,151
8,347
818.211
Cost of Revenue
406.639
704.705
766.957
2,053
502.789
Gross Profit
831.714
906.813
1,384
6,294
315.422
Operating Expenses
Research Development
-
3.285
1,152
-
204.69
Selling General and Administrative
4,314
6,096
7,243
20,510
4,781
Total Operating Expenses
4,318
6,100
8,476
21,344
5,009
Operating Income or Loss
-3,486
-5,193
-7,092
-15,050
-4,694
Interest Expense
304.386
176.836
1,463
299.331
162.2
Total Other Income/Expenses Net
-4,575
570.33
2,096
-14,459
-52.592
Income Before Tax
-7,861
-4,799
-6,459
-29,808
-4,909
Income from Continuing Operations
-7,861
-4,799
-6,459
-29,808
-4,909
Net Income
-7,861
-4,799
-6,459
-29,808
-4,909
Net Income available to common shareholders
-7,861
-4,799
-6,781
-33,196
-5,478
Basic EPS
-
-30.00
-60.00
-340.00
-230.00
Diluted EPS
-
-30.00
-60.00
-340.00
-230.00
Basic Average Shares
-
145.736
111.491
96.37
23.458
Diluted Average Shares
-
145.736
111.491
96.37
23.458
EBITDA
-
-4,607
-4,915
-28,674
-4,723